Gooding WE - Search Results

1

Combined inhibition of c-Src and epidermal growth factor receptor abrogates growth and invasion of head and neck squamous cell carcinoma.

Koppikar P, Choi SH, Egloff AM, Cai Q, Suzuki S, Freilino M, Nozawa H, Thomas SM, Gooding WE, Siegfried JM, Grandis JR. Koppikar P, et al. Among authors: gooding we. Clin Cancer Res. 2008 Jul 1;14(13):4284-91. doi: 10.1158/1078-0432.CCR-07-5226. Clin Cancer Res. 2008. PMID: 18594011 Free PMC article.

2

Preliminary trial of nonrecombinant interferon alpha in recurrent squamous cell carcinoma of the head and neck.

Vlock DR, Johnson J, Myers E, Day R, Gooding WE, Whiteside T, Pelch K, Sigler B, Wagner R, Colao D, et al. Vlock DR, et al. Among authors: gooding we. Head Neck. 1991 Jan-Feb;13(1):15-21. doi: 10.1002/hed.2880130103. Head Neck. 1991. PMID: 1989925

3

Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival.

Rubin Grandis J, Melhem MF, Gooding WE, Day R, Holst VA, Wagener MM, Drenning SD, Tweardy DJ. Rubin Grandis J, et al. Among authors: gooding we. J Natl Cancer Inst. 1998 Jun 3;90(11):824-32. doi: 10.1093/jnci/90.11.824. J Natl Cancer Inst. 1998. PMID: 9625170

4

A phase III randomized trial of dacarbazine and carboplatin with and without tamoxifen in the treatment of patients with metastatic melanoma.

Agarwala SS, Ferri W, Gooding W, Kirkwood JM. Agarwala SS, et al. Cancer. 1999 May 1;85(9):1979-84. Cancer. 1999. PMID: 10223239 Clinical Trial.

5

Spontaneous ex vivo apoptosis of peripheral blood mononuclear cells in patients with head and neck cancer.

Saito T, Kuss I, Dworacki G, Gooding W, Johnson JT, Whiteside TL. Saito T, et al. Clin Cancer Res. 1999 Jun;5(6):1263-73. Clin Cancer Res. 1999. PMID: 10389908

6

Spontaneous apoptosis of CD8+ T lymphocytes in peripheral blood of patients with advanced melanoma.

Saito T, Dworacki G, Gooding W, Lotze MT, Whiteside TL. Saito T, et al. Clin Cancer Res. 2000 Apr;6(4):1351-64. Clin Cancer Res. 2000. PMID: 10778963

7

Determination of intermediate biomarker expression levels by quantitative reverse transcription-polymerase chain reaction in oral mucosa of cancer patients treated with liarozole.

Zeng Q, Smith DC, Suscovich TJ, Gooding WE, Trump DL, Grandis JR. Zeng Q, et al. Among authors: gooding we. Clin Cancer Res. 2000 Jun;6(6):2245-51. Clin Cancer Res. 2000. PMID: 10873074 Clinical Trial.

8

Human leukocyte antigen class I allelic and haplotype loss in squamous cell carcinoma of the head and neck: clinical and immunogenetic consequences.

Grandis JR, Falkner DM, Melhem MF, Gooding WE, Drenning SD, Morel PA. Grandis JR, et al. Among authors: gooding we. Clin Cancer Res. 2000 Jul;6(7):2794-802. Clin Cancer Res. 2000. PMID: 10914726

9

The role of topical antibiotic prophylaxis in patients undergoing contaminated head and neck surgery with flap reconstruction.

Simons JP, Johnson JT, Yu VL, Vickers RM, Gooding WE, Myers EN, Pou AM, Wagner RL, Grandis JR. Simons JP, et al. Among authors: gooding we. Laryngoscope. 2001 Feb;111(2):329-35. doi: 10.1097/00005537-200102000-00026. Laryngoscope. 2001. PMID: 11210884 Clinical Trial.

10

Prognostic value of quantitative reverse transcription-polymerase chain reaction in lymph node-negative esophageal cancer patients.

Godfrey TE, Raja S, Finkelstein SD, Gooding WE, Kelly LA, Luketich JD. Godfrey TE, et al. Among authors: gooding we. Clin Cancer Res. 2001 Dec;7(12):4041-8. Clin Cancer Res. 2001. PMID: 11751499

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

248 results

Search Page

Filters